Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Turbo+ Device for Adherence in Pediatric Asthma
NCT03788395Phase 4Completed
- Sponsor
- CNR-Institute for Biomedical Research and Innovation
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by CNR-Institute for Biomedical Research and Innovation. Primary endpoint: Medication Adherence Rating Scale at 3 months. Started Jan 2019; status: completed.
Beyond the preview
Go deeper on NCT03788395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03788395.